Ancora Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $372K | Sell |
836
-2
| -0.2% | -$891 | 0.01% | 588 |
|
|
2025
Q1 | $406K | Buy |
838
+31
| +4% | +$15K | 0.01% | 557 |
|
|
2024
Q4 | $325K | Hold |
807
| – | – | 0.01% | 596 |
|
|
2024
Q3 | $375K | Buy |
807
+3
| +0.4% | +$1.4K | 0.01% | 556 |
|
|
2024
Q2 | $377K | Sell |
804
-78
| -9% | -$36.6K | 0.01% | 535 |
|
|
2024
Q1 | $369K | Buy |
882
+133
| +18% | +$55.6K | 0.01% | 539 |
|
|
2023
Q4 | $305K | Sell |
749
-80
| -10% | -$32.6K | 0.01% | 571 |
|
|
2023
Q3 | $288K | Buy |
829
+56
| +7% | +$19.5K | 0.01% | 566 |
|
|
2023
Q2 | $272K | Buy |
773
+15
| +2% | +$5.28K | 0.01% | 575 |
|
|
2023
Q1 | $239K | Buy |
758
+227
| +43% | +$71.5K | 0.01% | 597 |
|
|
2022
Q4 | $153K | Buy |
531
+89
| +20% | +$25.6K | ﹤0.01% | 704 |
|
|
2022
Q3 | $128K | Sell |
442
-16
| -3% | -$4.63K | ﹤0.01% | 805 |
|
|
2022
Q2 | $129K | Buy |
458
+83
| +22% | +$23.4K | ﹤0.01% | 859 |
|
|
2022
Q1 | $98K | Buy |
375
+125
| +50% | +$32.7K | ﹤0.01% | 1028 |
|
|
2021
Q4 | $55K | Buy |
250
+66
| +36% | +$14.5K | ﹤0.01% | 1213 |
|
|
2021
Q3 | $33K | Buy |
184
+74
| +67% | +$13.3K | ﹤0.01% | 1296 |
|
|
2021
Q2 | $22K | Hold |
110
| – | – | ﹤0.01% | 1307 |
|
|
2021
Q1 | $24K | Hold |
110
| – | – | ﹤0.01% | 1232 |
|
|
2020
Q4 | $26K | Buy |
110
+74
| +206% | +$17.5K | ﹤0.01% | 999 |
|
|
2020
Q3 | $10K | Buy |
36
+30
| +500% | +$8.33K | ﹤0.01% | 1117 |
|
|
2020
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 1246 |
|
|
2020
Q1 | $1K | Hold |
6
| – | – | ﹤0.01% | 1335 |
|
|
2019
Q4 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 1315 |
|